Dosage FormSolution for injection
Strength215.2 mg/ml
IndicationFor treatment of cerebrovascular disorders. Especially in the following indications:
– Senile dementia of Alzheimer’s type.
– Vascular dementia.
– Stroke.
– Craniocerebral trauma (commotio and contusio).

Cerebrolysin® is a prescription medication. Information for healthcare professionals only.
See the Summary of Product Characteristics for full information about the medication.

Notice to U.S. Visitors

Please be advised that Cerebrolysin is not registered with the U.S. Food and Drug Administration (FDA) and is not approved for sale or distribution in the United States.

Cerebrolysin is a prescription medication for use under the supervision of an authorized health care professional. For any medical inquiries, please consult with a healthcare professional.